Recruiting Diabetic Retinopathy Studies in Walnut Creek
About Diabetic Retinopathy Clinical Trials in Walnut Creek
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 3 diabetic retinopathy clinical trials recruiting participants in Walnut Creek, CA. These studies are seeking a combined 656 participants. Research is being sponsored by 4D Molecular Therapeutics, Genentech, Inc., Boehringer Ingelheim. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Walnut Creek — FAQ
Are there diabetic retinopathy clinical trials in Walnut Creek?
Yes, there are 3 diabetic retinopathy clinical trials currently recruiting in Walnut Creek, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Walnut Creek?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.
Are clinical trials in Walnut Creek free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 3 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated October 16, 2026 from ClinicalTrials.gov